Molecule
Proparacaine is a local anesthetic indicated for procedures in which a topical ophthalmic anesthetic is indicated. It is available as eye drops for ophthalmic use. MedsAcross supplies Proparacaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
ALCAINE™ ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.
Source: US FDA prescribing information
Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating. Short Corneal and Conjunctival Procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses. NOTE: ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5% should be clear to straw-color. If the solution becomes darker, discard the solution.
Source: US FDA prescribing information
ALCAINE™ ophthalmic solution should be considered contraindicated in patients with known hypersensitivity to any of the ingredients of this preparation.
Source: US FDA prescribing information
NOT FOR INJECTION - FOR TOPICAL OPHTHALMIC USE ONLY. Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss. ALCAINE™ ophthalmic solution is indicated for administration under the direct supervision of a healthcare provider. ALCAINE™ ophthalmic solution is not intended for patient self-administration.
Source: US FDA prescribing information
Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. Corneal edema has been reported following the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and, sometimes, iritis with descemetitis has been reported. Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has also been reported.
Source: US FDA prescribing information
Store bottles under refrigeration at 2°C to 8°C (36°F to 46°F). Bottle must be stored in unit carton to protect contents from light.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Proparacaine, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Proparacaine 5 mg/mL eye dropsOphthalmic Cold chainGeneric name | — | US FDA | Available on request |
| Alcaine 5 mg/mL eye dropsOphthalmic Cold chain | Alcon Laboratories | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 1 July 1953 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 2 presentations of Proparacaine and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Proparacaine, including Alcaine.
Yes. The US FDA first approved Proparacaine on 1 July 1953, according to Drugs@FDA.
At least one listed presentation of Proparacaine must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.
Proparacaine is classified under ATC code S01HA04 (Proparacaine).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.